Madrigal Pharmaceuticals, Inc. (FRA:YDO1)
511.60
-1.60 (-0.31%)
At close: Nov 28, 2025
Madrigal Pharmaceuticals Employees
Madrigal Pharmaceuticals had 528 employees as of December 31, 2024. The number of employees increased by 152 or 40.43% compared to the previous year.
Employees
528
Change (1Y)
152
Growth (1Y)
40.43%
Revenue / Employee
€1,195,544
Profits / Employee
€466,707
Market Cap
11.32B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 528 | 152 | 40.43% |
| Dec 31, 2023 | 376 | 284 | 308.70% |
| Dec 31, 2022 | 92 | 21 | 29.58% |
| Dec 31, 2021 | 71 | 29 | 69.05% |
| Dec 31, 2020 | 42 | 13 | 44.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Madrigal Pharmaceuticals News
- 10 days ago - Madrigal Pharmaceuticals (MDGL) Sees Analyst Upgrade with Target Price Raised to $620 | MDGL ... - GuruFocus
- 11 days ago - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 days ago - Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 11 days ago - Madrigal Pharmaceuticals (MDGL): Oppenheimer Raises Price Target to $650 | MDGL Stock News - GuruFocus
- 12 days ago - Madrigal Pharmaceuticals (MDGL) Rating Maintained and Price Target Raised by Truist Securities ... - GuruFocus
- 14 days ago - Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences - GlobeNewsWire
- 18 days ago - Madrigal Pharmaceuticals (MDGL): Analyst Maintains Buy Rating, Raises Price Target | MDGL Stock News - GuruFocus
- 19 days ago - MDGL Crosses Above Average Analyst Target - Nasdaq